CureVac, AstraZeneca Fall Premarket; Ford Rises
By Peter Nurse
Investing.com — Stocks in focus in premarket trade on Thursday, June 17th. Please refresh for updates.
-
CureVac (NASDAQ:CVAC) stock slumped 46% after the drugmaker said preliminary data showed its main candidate for a Covid-19 vaccine was only 47% effective at protecting against the virus, missing its main target.
-
AstraZeneca (NASDAQ:AZN) ADR fell 0.7% after Australia’s decision to limit the company’s Covid-19 vaccine shots to those aged 60 and above.
-
Ford Motor Company (NYSE:F) stock rose 1.6% following a newspaper report that the auto giant has agreed to pay just short of $500 million to the Brazilian state of Bahia after deciding to close its plants in Brazil, to compensate for all the subsidies it received.
-
Voya Financial (NYSE:VOYA) stock fell 0.8% after Citigroup downgraded the financial services company to ‘neutral’ from ‘buy’, citing a lack of catalysts to boost the stock.
-
Boot Barn (NYSE:BOOT) stock rose 1.3% after Citigroup upgraded its stance on the retailer of western-style clothes to ‘buy’ from ‘neutral’, saying the economic recovery will boost the company’s financials.
-
Honest Company (NASDAQ:HNST) stock fell 6.2% after the consumer goods company, founded by actress Jessica Alba, reported a wider-than-expected loss in its first quarter as a public company even after reporting a 12% revenue gain.
-
Fisker (NYSE:FSR) stock rose 2% after the electric vehicle maker signed a long-term manufacturing agreement with Magna International (NYSE:MGA), up 0.1%, using Magna’s carbon-neutral facility in Austria.
-
Jack In The Box (NASDAQ:JACK) stock rose 0.8% after RBC Capital started coverage on the fast food retailer with an ‘outperform’ rating, saying it is outperforming some of its key competitors but still trading at a discount.